OTCMKTS:MDCL

Medicine Man Technologies Stock Forecast, Price & News

$2.22
+0.03 (+1.37 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.10
Now: $2.22▼
$2.22
50-Day Range
$1.90
MA: $2.34▼
$2.99
52-Week Range
$1.05
Now: $2.22▼
$4.05
Volume22,574 shs
Average Volume84,948 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Medicine Man Technologies, Inc. provides advisory and consulting services related to cannabis cultivation. It offers consulting, application and licensing, cultivation technology, dispensary operations, facility design and training services. The firm products include Nutrients, The Big Tomato and Three A Light. The company was founded by Andrew Williams on March 20, 2014 and is headquartered in Denver, CO.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Business Services
Sub-IndustryCannabis
SectorIndustrials
Current SymbolOTCMKTS:MDCL
Previous SymbolNASDAQ:MDCL
CUSIPN/A
CIK1622879
Webmedicinemantechnologies.com
Phone(303) 371-0387
Employees25
Year FoundedN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

Headlines

Medicine Man Technologies Inc hosts conference call for investors
March 26, 2021 |  markets.businessinsider.com
NJ Sen. Menendez Presents Cannabis Insurance Bill To Enable 'Burgeoning Industry To Thrive'
March 20, 2021 |  benzinga.com
Why Cannabinoids Are Here To Stay
March 20, 2021 |  benzinga.com
Schwazze Shares Bounce On Heels Of Five Star Buds Deal Valued At $72.3M
March 5, 2021 |  benzinga.com
Sundial Stock Rebounds Pre-Market After Thursday's Slump
February 13, 2021 |  benzinga.com
Why The UFC Decision To Support Psychedelics Research Is A Very Big Deal
January 22, 2021 |  benzinga.com
Schwazze Acquires 6 Star Buds Dispensaries For $37.1M, Plans To Buy 7 More In 2021
December 23, 2020 |  benzinga.com
Denied Medicine As A Punishment: Cannabis And Parole
October 14, 2020 |  benzinga.com
Medicine Man Technologies Acquisiton Target, MedPharm, to Launch a Landmark Randomized Clinical Trial Taking Aim at Treating
July 20, 2020 |  www.bloomberg.com
Schwazze, Formerly Operating as Medicine Man Technologies, Inc., to Participate in Two Upcoming Virtual Investor Conferences
May 29, 2020 |  finance.yahoo.com
Schwazze, Formerly Operating as Medicine Man Technologies, Inc., to Host First Quarter 2020 Conference Call and Webcast on May 11, 2020
May 7, 2020 |  finance.yahoo.com
High Times Buys 13 Dispensaries from Harvest, Gains Instant Cannabis Retail Foothold Before Listing
April 28, 2020 |  finance.yahoo.com
Medicine Man Technologies changes trade name to Schwazze
April 20, 2020 |  seekingalpha.com
Medicine Man Technologies, Inc. Announces Corporate Brand Change to Schwazze
April 20, 2020 |  finance.yahoo.com
Schwazze, Formerly Known as Medicine Man Technologies, Inc., Announces the Closing of the Mesa Organics Acquisition
April 20, 2020 |  finance.yahoo.com
Medicine Man Technologies, Inc. (MDCL) CEO Andy Williams on Q4 2019 Results - Earnings Call Transcript
March 31, 2020 |  seekingalpha.com
Medicine Man Technologies, Inc. (MDCL)
March 30, 2020 |  ca.finance.yahoo.com
Medicine Man Technologies Launches Online Marketplace for Strategic Partners’ Dispensary Operations
March 27, 2020 |  finance.yahoo.com
Medicine Man Technologies to Host Fourth Quarter 2019 Conference Call and Webcast on March 30, 2020
March 25, 2020 |  finance.yahoo.com
Medicine Man Taps Nirup Krishnamurthy To Oversee Acquisitions, Synergies
March 18, 2020 |  www.benzinga.com
See More Headlines

MarketRank™

Overall MarketRank™

0.54 out of 5 stars

Industrials Sector

129th out of 364 stocks

Business Services Industry

8th out of 24 stocks

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$2.22
+0.03 (+1.37 %)
(As of 04/9/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MDCL News and Ratings via Email

Sign-up to receive the latest news and ratings for MDCL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Medicine Man Technologies (OTCMKTS:MDCL) Frequently Asked Questions

What stocks does MarketBeat like better than Medicine Man Technologies?

Wall Street analysts have given Medicine Man Technologies a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Medicine Man Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Medicine Man Technologies' stock price been impacted by COVID-19 (Coronavirus)?

Medicine Man Technologies' stock was trading at $1.64 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MDCL stock has increased by 35.1% and is now trading at $2.2150.
View which stocks have been most impacted by COVID-19.

Who are Medicine Man Technologies' key executives?

Medicine Man Technologies' management team includes the following people:
  • Justin Dye, Executive Chairman & Chief Executive Officer
  • Nancy Bush Huber, Chief Financial Officer
  • Nirup Krishnamurthy, Chief Integration & Information Officer
  • Lee Alexander Dayton, Chief Administrative Officer
  • Marc Harvill, Manager-Business Development

Who are some of Medicine Man Technologies' key competitors?

Some companies that are related to Medicine Man Technologies include Canopy Growth (WEED), Innovative Industrial Properties (IIPR), GrowGeneration (GRWG), Leaf Mobile (LEAF), OrganiGram (OGI), 22nd Century Group (XXII), Emblem (EMC), ICC Labs (ICC), Bioventix (BVXP), KushCo (KSHB), NSAV (NSAV), Terra Tech (TRTC), General Cannabis (CANN), Pervasip (PVSP) and Grow Capital (GRWC).
View all of MDCL's competitors.

What other stocks do shareholders of Medicine Man Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medicine Man Technologies investors own include (CGC), Curaleaf (CURLF), Aurora Cannabis (ACB), Charlotte's Web (CWBHF), Trulieve Cannabis (TCNNF), KushCo (KSHB), OrganiGram (OGI), Green Thumb Industries (GTBIF), Innovative Industrial Properties (IIPR) and CV Sciences (CVSI).

What is Medicine Man Technologies' stock symbol?

Medicine Man Technologies trades on the OTCMKTS under the ticker symbol "MDCL."

How do I buy shares of Medicine Man Technologies?

Shares of MDCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Medicine Man Technologies' stock price today?

One share of MDCL stock can currently be purchased for approximately $2.22.

How many employees does Medicine Man Technologies have?

Medicine Man Technologies employs 25 workers across the globe.

What is Medicine Man Technologies' official website?

The official website for Medicine Man Technologies is medicinemantechnologies.com.

Where are Medicine Man Technologies' headquarters?

Medicine Man Technologies is headquartered at 4880 Havana St, DENVER, CO 80239-2402, United States.

How can I contact Medicine Man Technologies?

Medicine Man Technologies' mailing address is 4880 Havana St, DENVER, CO 80239-2402, United States. The company can be reached via phone at (303) 371-0387.


This page was last updated on 4/12/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.